Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease: Systematic review and meta-analysis.

Medicine (Baltimore) · 2024 · PMC11224812 · PMID 38968479

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

[ 42 ] Hence, the consistency of the results between the present study and the former analysis revealed that racial difference might not be significant on the effectiveness of olanzapine and risperidone.

also in 670 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.